The PurpleLab^® Resource Center

PurpleLab was selected to present a poster at PMSA 2024 on imputing SDOH information on pharmacy claims. This study was centered around prescription fill rates of Semaglutides in the adolescent population. In December of 2022, the FDA approved adolescents BMI at or above the 95th percentile eligible for a Semaglutide prescription. PurpleLab used a combination…

A large CRO has incorporated PurpleLab data directly into their workflow to support all therapeutic areas and phases of clinical trial work from RWE and pre-award through phase IV and beyond including market access and HEOR work. This strategy has been incorporated for all of their clients.  “The data and services provided by PurpleLab have…

Payers are continuously looking to improve health outcomes. Removing barriers to care and improving care access through analyzing social determinants of health (SDOH) data is a key strategy. The social determinants of health (SDOH) include education, housing, transportation, income as well as other factors including where people are born, raised, live and work that impact their…